Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Pfeffer

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Cancers|November 2, 2019
Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal MelanomaFrancesca Piaggio, Veronica Tozzo, Cinzia Bernardi, et al.
Molecular Oncology|February 4, 2014
miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2Emanuel Kronski, Micol E Fiori, Ottavia Barbieri, et al.
Oncotarget|September 15, 2016
A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivoAdriana Amaro, Giovanna Angelini, Valentina Mirisola, et al.
Plos One|January 24, 2012
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progressionRosaria Gangemi, Valentina Mirisola, Gaia Barisione, et al.
Cancers|October 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer TherapyMelania Grottoli, Paolo Carrega, Lodovica Zullo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsDaniela Di Paolo, Fabio Pastorino, Chiara Brignole, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2023
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cellsAdriana Amaro, Francesco Reggiani, Daniela Fenoglio, et al.
Cancers|August 7, 2019
Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal MelanomaMehmet Dogrusöz, Andrea Ruschel Trasel, Jinfeng Cao, et al.
Cell Cycle (Georgetown, Tex.)|November 19, 2013
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancerCecilia Marini, Barbara Salani, Michela Massollo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2022
In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutationsFrancesca Piaggio, Michela Croce, Francesco Reggiani, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Cancers|November 2, 2019
Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal MelanomaFrancesca Piaggio, Veronica Tozzo, Cinzia Bernardi, et al.
Molecular Oncology|February 4, 2014
miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2Emanuel Kronski, Micol E Fiori, Ottavia Barbieri, et al.
Oncotarget|September 15, 2016
A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivoAdriana Amaro, Giovanna Angelini, Valentina Mirisola, et al.
Plos One|January 24, 2012
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progressionRosaria Gangemi, Valentina Mirisola, Gaia Barisione, et al.
Cancers|October 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer TherapyMelania Grottoli, Paolo Carrega, Lodovica Zullo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsDaniela Di Paolo, Fabio Pastorino, Chiara Brignole, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2023
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cellsAdriana Amaro, Francesco Reggiani, Daniela Fenoglio, et al.
Cancers|August 7, 2019
Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal MelanomaMehmet Dogrusöz, Andrea Ruschel Trasel, Jinfeng Cao, et al.
Cell Cycle (Georgetown, Tex.)|November 19, 2013
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancerCecilia Marini, Barbara Salani, Michela Massollo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2022
In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutationsFrancesca Piaggio, Michela Croce, Francesco Reggiani, et al.
Pageof 11